Header Logo

Connection

Bradley Gehrs to Humans

This is a "connection" page, showing publications Bradley Gehrs has written about Humans.
Connection Strength

0.051
  1. Autoimmune hemolytic anemia. Am J Hematol. 2002 Apr; 69(4):258-71.
    View in: PubMed
    Score: 0.011
  2. Diffuse Marrow Involvement in Metastatic Osteosarcoma: An Unusual Presentation. J Oncol Pract. 2017 06; 13(6):401-403.
    View in: PubMed
    Score: 0.008
  3. Intravascular large B-cell lymphoma with hemophagocytic syndrome (Asian variant) in a Caucasian patient. Int J Clin Exp Pathol. 2012; 5(5):448-54.
    View in: PubMed
    Score: 0.006
  4. A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)? Cancer Genet Cytogenet. 2010 Dec; 203(2):348-51.
    View in: PubMed
    Score: 0.005
  5. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther. 2009 Jul; 8(7):1867-77.
    View in: PubMed
    Score: 0.005
  6. Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease. J Pathol. 2008 Dec; 216(4):514-20.
    View in: PubMed
    Score: 0.005
  7. Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol. 2007 Mar 15; 559(1):21-31.
    View in: PubMed
    Score: 0.004
  8. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res. 2006 Jul; 4(7):437-47.
    View in: PubMed
    Score: 0.004
  9. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J Urol. 2005 May; 173(5):1552-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.